Clinical Trial Update: ASIS for Enbrel in Plaque Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ASIS evaluating Enbrel (etanercept) in plaque psoriasis across Phase 1/Phase 2; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: ASIS Corporation | Conditions: Plaque Psoriasis. | Phase 1, Phase 2 | Status: UNKNOWN